节点文献

生物制品病毒安全性控制的核心理念探讨

Discussion on the core concept for viral safety of biological products

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭怀祖杨美花杨汇川公雪杰侯盛张华捷李长清董关木李敏孟淑芳侯继锋郭中平

【Author】 GUO Huai-zu;YANG Mei-hua;YANG Hui-chuan;GONG Xue-jie;HOU Sheng;ZHANG Hua-jie;LI Chang-qing;DONG Guan-mu;LI Min;MENG Shu-fang;HOU Ji-feng;GUO Zhong-ping;State Key Laboratory of Antibody Medicine and Targeted Therapy,NMPA Key Laboratory of Quality Control for Therapeutic Monoclonal Antibodies;Xiamen Amoytop Biotech Co.,Ltd.;China National Biotec Group;Sinovac Biotech Ltd.;Shanghai Biomabs Pharmaceuticals Co., Ltd.;National Institutes for Food and Drug Control;Institute of Blood Transfusion, Chinese Academy of Medical Science;Center for Drug Evaluation, National Medical Products Administration;Division of Biological Product Standards,Chinese Pharmacopoeia Commission;

【通讯作者】 郭中平;

【机构】 抗体药物与靶向治疗国家重点实验室国家药品监督管理局治疗类单抗质量控制重点实验室厦门特宝生物工程股份有限公司中国生物技术股份有限公司北京科兴生物制品有限公司上海百迈博制药有限公司中国食品药品检定研究院中国医学科学院输血研究所国家药品监督管理局药品审评中心国家药典委员会生物制品标准处

【摘要】 生物制品的一个共同特点就是存在病毒污染的风险性。近年来,我国生物药物产业发展迅猛,随着新技术的发展以及越来越多的生物制品被批准,使用人群不断扩大,对生物制品的安全性问题提出了更高要求。与此同时,国内外关于生物制品病毒安全性控制,已经出台了一系列技术要求和指导原则。本文分析了国内外生物制品病毒安全性控制的法规,归纳提炼了可能的生物制品病毒安全性控制核心理念,可为技术法规的建立和生物制品质量控制提供参考。生物制品病毒污染的安全性只有通过贯彻病毒安全性控制理念,采取综合措施,才能得到确切的保障。

【Abstract】 The risk of viral contamination is a feature common to biotechnology or biological products. In recent years, China’s biopharmaceutical industry has made substantial strides and developed rapidly. With the development and implementation of new technologies and the approval of more and more biological products, the user of biological products has been rapidly expanding, which puts forward higher requirements for the safety of biological products. At the same time, in China and abroad, a series of technical requirements and guidelines have been issued for viral safety control of biological products. In this paper, the regulations of viral safety control of biological products in China and abroad were analyzed, and the possible core concept of viral safety control of biological products was summarized and refined to provide reference for the establishment of technical regulations and quality control of biological products. The potential viral contamination of biotechnology or biological products can only be ensured by implementing the concept of viral safety control and taking comprehensive measures.

【基金】 国家药品监督管理局“药品医疗器械审评审批制度改革专项课题”(ZG2018-3-01)
  • 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2020年24期
  • 【分类号】R95
  • 【被引频次】3
  • 【下载频次】582
节点文献中: 

本文链接的文献网络图示:

本文的引文网络